Matches in Wikidata for { <http://www.wikidata.org/entity/Q90580365> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q90580365 description "article scientifique publié en 2020" @default.
- Q90580365 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90580365 description "scientific article published on 22 March 2020" @default.
- Q90580365 description "wetenschappelijk artikel" @default.
- Q90580365 description "наукова стаття, опублікована 22 березня 2020" @default.
- Q90580365 name "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 name "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 type Item @default.
- Q90580365 label "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 label "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 prefLabel "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 prefLabel "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 P1433 Q90580365-93F61157-BE32-4E37-8AD3-050FFA435EEE @default.
- Q90580365 P1476 Q90580365-F7A6DB26-FA49-47E3-87FC-B5D121F41335 @default.
- Q90580365 P2093 Q90580365-D8974FB5-CA76-464E-8C7B-B36E1EE5E7AA @default.
- Q90580365 P31 Q90580365-B06D43EF-2451-49AD-8A5E-45645990298D @default.
- Q90580365 P31 Q90580365-dc789fc7-2c70-4c74-b55c-6a23fa99fc07 @default.
- Q90580365 P356 Q90580365-1353DDAB-76F3-4846-BBBE-C0B24EA87E99 @default.
- Q90580365 P577 Q90580365-F72EBB68-434C-4A9A-9713-DC838B01AD23 @default.
- Q90580365 P698 Q90580365-2E38A94F-DC83-4EC4-A3AF-EF3026DE197A @default.
- Q90580365 P921 Q90580365-12D7FA45-7AED-4887-B76C-344CE4AE7AF1 @default.
- Q90580365 P921 Q90580365-4FBEF60C-DF2C-45A6-AA97-284107819AC9 @default.
- Q90580365 P921 Q90580365-86EFD8C9-13B0-414F-B80D-E1D32D6DC765 @default.
- Q90580365 P921 Q90580365-F950339C-FF47-4011-9FA0-26CFF2E11772 @default.
- Q90580365 P356 S40262-020-00885-Z @default.
- Q90580365 P698 32201911 @default.
- Q90580365 P1433 Q5133788 @default.
- Q90580365 P1476 "Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease" @default.
- Q90580365 P2093 "André J Scheen" @default.
- Q90580365 P31 Q13442814 @default.
- Q90580365 P31 Q7318358 @default.
- Q90580365 P356 "10.1007/S40262-020-00885-Z" @default.
- Q90580365 P577 "2020-03-22T00:00:00Z" @default.
- Q90580365 P698 "32201911" @default.
- Q90580365 P921 Q3025883 @default.
- Q90580365 P921 Q323936 @default.
- Q90580365 P921 Q725307 @default.
- Q90580365 P921 Q736715 @default.